Skip to content
AnalystLens

International Flavors & Fragrances Annual Report, Year Ended Dec 31, 2000

Filing Date
Filed March 30, 2001
Period End
December 31, 2000
Security
IFF
In the record · 2016–202610-K1110-Q338-K151

IFF filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 151 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Jan ’20Jan ’20
  3. Leadership change8-K · Feb ’22Feb ’22
  4. Leadership change8-K · Oct ’25Oct ’25

Summary

Summary of the 10-K filed March 30, 2001. Cited figures are marked; the original filing is the authoritative source.

International Flavors & Fragrances Inc. (IFF) reported 2000 net sales of $1,462.8 milliona, up from $1,439.5 million in 1999, with net income falling to $123.0 million from $162.0 million, or $1.22 per diluted share versus $1.53.

The results include $41.3 millionb of nonrecurring charges and $7.0 million of amortization of goodwill and other intangibles tied to the November 3, 2000 acquisition of Bush Boake Allen Inc. (BBA) for approximately $970.0 million in cash. Excluding BBA, the filing states that 2000 sales declined 3% versus 1999, with the continuing strong U.S. dollar reducing reported sales; the filing says reported sales would have been about 5% higher at constant exchange rates. The balance sheet changed significantly with the acquisition.

Total assets rose to $2.49 billionc from $1.40 billion, intangible assets reached $755.9 million, and commercial paper outstanding was $1,209.4 million at an average rate of 7.4%. Total shareholders' equity fell to $631.3 million from $858.5 million, reflecting $201.0 million of 2000 treasury stock purchases. The current ratio dropped to 0.9 from 2.3.

Management is pursuing permanent long-term financing for much of the BBA-related debt, expected in the first half of 2001. Management is restructuring the business. The company is reorganized around Business Development and Operations, with a single regional manager for each geographic cluster effective January 1, 2001.

The filing projects about $70.0 milliond in annual BBA synergy savings, with roughly half expected in 2001, and total reorganization costs of $90.0 million to $100.0 million through 2002. On February 20, 2001, the Board authorized management to divest a significant portion of the BBA aroma chemicals business, which had annual sales of about $100.0 million, with proceeds to pay down debt. The quarterly dividend was cut by 60% to $0.15 per share beginning in the fourth quarter of 2000.

Key Highlights

  1. 2000 net sales rose 2% to $1,462.8 million, while net income fell to $123.0 million ($1.22 per diluted share) from $162.0 million ($1.53) in 1999.
  2. Acquisition of Bush Boake Allen Inc. for about $970.0 million in cash on November 3, 2000, funded initially by commercial paper and bank borrowings.
  3. Excluding BBA, 2000 sales declined 3%; the filing cites a strong U.S. dollar, which it says reduced reported sales by roughly 5%.
  4. Commercial paper rose to $1,209.4 million at December 31, 2000, and the current ratio fell to 0.9 from 2.3.
  5. Shareholders' equity fell to $631.3 million from $858.5 million, reflecting $201.0 million of treasury stock purchases in 2000.
  6. Projected BBA synergy savings of about $70.0 million annually, with about half expected in 2001; reorganization costs of $90.0 million to $100.0 million through 2002.
  7. Board authorized divestiture of a significant portion of the BBA aroma chemicals business (about $100.0 million in annual sales); quarterly dividend cut 60% to $0.15 per share.

Frequently Asked Questions

  1. Why did net income decline in 2000 despite higher sales?

    Net income fell to $123.0 million from $162.0 million. The filing attributes this to $41.3 million of nonrecurring charges, $7.0 million of goodwill and intangible amortization from the BBA acquisition, higher interest expense of $25.1 million (versus $5.2 million), and a higher cost of goods sold at 56.9% of sales versus 56.0% in 1999, partly due to BBA and weak North American absorption.

  2. How is the BBA acquisition being financed, and what is the debt picture?

    The acquisition was initially financed through short-term debt and bank borrowings, later replaced largely by commercial paper of $1,209.4 million at an average rate of 7.4%. Of this, $400.0 million is classified as long-term, and the company is arranging permanent long-term financing for a substantial portion, expected in the first half of 2001. The company also has $1,300.0 million of backstop revolving credit facilities, with no amounts drawn.

  3. Did the company change its dividend in 2000?

    Yes. In September 2000 the Board reduced the quarterly dividend by 60% to $0.15 per share, beginning with the fourth-quarter 2000 dividend. Total dividends paid were $155.5 million in 2000, compared with $161.2 million in 1999.

  4. What restructuring and integration actions are planned?

    The company reorganized into Business Development and Operations and named a single regional manager for each geographic cluster effective January 1, 2001. It expects total reorganization costs of $90.0 million to $100.0 million through 2002, with annual savings of $25.0 million to $30.0 million by 2003. For BBA integration, it expects about $70.0 million in annual savings and $75.0 million to $80.0 million in implementation costs, plus $45.0 million to $50.0 million of related capital spending.

  5. What did the company say about portfolio changes after year-end?

    On February 20, 2001, the Board authorized management to divest a significant portion of the aroma chemicals business acquired with BBA, which had annual sales of about $100.0 million in 2000. Preliminary discussions with potential buyers had begun, but no definitive agreement had been reached. The company intends to use the proceeds to pay down debt.